Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
Portal hypertension is a major pathophysiological condition in patients with cirrhosis. This accounts for the occurrence and severity of the various manifestations. The degree is determined by the portal pressure or hepatic venous pressure gradients, both of which are obtained by invasive interventi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-12-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1057045/full |
| _version_ | 1828116181966389248 |
|---|---|
| author | Hitoshi Maruyama Maki Tobari Hiroaki Nagamatsu Suichiro Shiina Tadashi Yamaguchi |
| author_facet | Hitoshi Maruyama Maki Tobari Hiroaki Nagamatsu Suichiro Shiina Tadashi Yamaguchi |
| author_sort | Hitoshi Maruyama |
| collection | DOAJ |
| description | Portal hypertension is a major pathophysiological condition in patients with cirrhosis. This accounts for the occurrence and severity of the various manifestations. The degree is determined by the portal pressure or hepatic venous pressure gradients, both of which are obtained by invasive interventional radiological procedures. Ultrasound (US) is a simple and minimally invasive imaging modality for the diagnosis of liver diseases. Owing to the availability of microbubble-based contrast agents and the development of imaging modes corresponding to contrast effects, contrast-enhanced US (CEUS) has become popular worldwide for the detailed evaluation of hepatic hemodynamics, diffuse liver disease, and focal hepatic lesions. Recent advancements in digital technology have enabled contrast-based demonstrations with improved resolution, leading to a wider range of applications. This review article describes the current role, benefits, and limitations of CEUS in the management of portal hypertension. |
| first_indexed | 2024-04-11T12:52:54Z |
| format | Article |
| id | doaj.art-62a3e36938d54ed3ab4432a11aeb598a |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-11T12:52:54Z |
| publishDate | 2022-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-62a3e36938d54ed3ab4432a11aeb598a2022-12-22T04:23:09ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-12-01910.3389/fmed.2022.10570451057045Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosisHitoshi Maruyama0Maki Tobari1Hiroaki Nagamatsu2Suichiro Shiina3Tadashi Yamaguchi4Department of Gastroenterology, Juntendo University, Tokyo, JapanDepartment of Gastroenterology, Juntendo University, Tokyo, JapanDepartment of Gastroenterology, Juntendo University, Tokyo, JapanDepartment of Gastroenterology, Juntendo University, Tokyo, JapanCenter for Frontier Medical Engineering, Chiba University, Chiba, JapanPortal hypertension is a major pathophysiological condition in patients with cirrhosis. This accounts for the occurrence and severity of the various manifestations. The degree is determined by the portal pressure or hepatic venous pressure gradients, both of which are obtained by invasive interventional radiological procedures. Ultrasound (US) is a simple and minimally invasive imaging modality for the diagnosis of liver diseases. Owing to the availability of microbubble-based contrast agents and the development of imaging modes corresponding to contrast effects, contrast-enhanced US (CEUS) has become popular worldwide for the detailed evaluation of hepatic hemodynamics, diffuse liver disease, and focal hepatic lesions. Recent advancements in digital technology have enabled contrast-based demonstrations with improved resolution, leading to a wider range of applications. This review article describes the current role, benefits, and limitations of CEUS in the management of portal hypertension.https://www.frontiersin.org/articles/10.3389/fmed.2022.1057045/fullultrasoundcontrast agentliverportal hypertensioncirrhosis |
| spellingShingle | Hitoshi Maruyama Maki Tobari Hiroaki Nagamatsu Suichiro Shiina Tadashi Yamaguchi Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis Frontiers in Medicine ultrasound contrast agent liver portal hypertension cirrhosis |
| title | Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| title_full | Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| title_fullStr | Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| title_full_unstemmed | Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| title_short | Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| title_sort | contrast enhanced ultrasonography for the management of portal hypertension in cirrhosis |
| topic | ultrasound contrast agent liver portal hypertension cirrhosis |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.1057045/full |
| work_keys_str_mv | AT hitoshimaruyama contrastenhancedultrasonographyforthemanagementofportalhypertensionincirrhosis AT makitobari contrastenhancedultrasonographyforthemanagementofportalhypertensionincirrhosis AT hiroakinagamatsu contrastenhancedultrasonographyforthemanagementofportalhypertensionincirrhosis AT suichiroshiina contrastenhancedultrasonographyforthemanagementofportalhypertensionincirrhosis AT tadashiyamaguchi contrastenhancedultrasonographyforthemanagementofportalhypertensionincirrhosis |